Overview
Premaitha Health develops and commercializes non-invasive prenatal testing (NIPT) solutions including the IONA test, enabling accurate early screening for chromosomal conditions such as Down syndrome.
More in Prenatal Testing
Genalyte Genomics
San Diego, CA, USA
Counsyl (now Myriad Women's Health)
San Francisco, CA, USA
ART Fertility Clinics
Abu Dhabi, Abu Dhabi, United Arab Emirates
Bourn Hall Fertility Clinic UK
Cambridge, England, United Kingdom
Center for Advanced Reproductive Services
Farmington, Connecticut, United States
Clínica Tambre
Madrid, Community of Madrid, Spain
Latest industry news
At-Home DNA Tests: What They Can and Can't Tell You About Inherited Health Risks
2026-09-09 · Industry
Carla Walker Act Targets Cold Case DNA Funding Gap as Forensic Genomics Gains Legislative Momentum
2026-09-08 · Policy
Roche Korea Recognized for Advancing Cancer Precision Medicine as Oncogenomics Gains Regional Momentum
2026-09-07 · Industry
Guardant Health Jumps 25% After FDA Clears First Genomic-Epigenomic Liquid Biopsy Panel
2026-09-06 · Product
Company details
Category
👶 Prenatal Testing
Location
Manchester, United Kingdom
Funding
Publicly traded on AIM London Stock Exchange; raised approximately £30 million across multiple funding rounds
Website
www.premaitha.comListed
2026-07-20
Is this your company?
Claim this listing to add your logo, full description, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach genomics professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →